Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease

BACKGROUND: Patients with IBD and chronic inflammation refractory to conventional therapy often demonstrate higher risk of serious complications. Combinations of immunosuppression and biological treatment as well as surgical intervention are often used in this patient group. Hence, there is need for...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindberg, Annelie, Eberhardson, Michael, Karlsson, Mats, Karlén, Per
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914086/
https://www.ncbi.nlm.nih.gov/pubmed/20604939
http://dx.doi.org/10.1186/1471-230X-10-73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914086/
https://www.ncbi.nlm.nih.gov/pubmed/20604939
http://dx.doi.org/10.1186/1471-230X-10-73

Ejemplares similares